https://scholars.lib.ntu.edu.tw/handle/123456789/516778
標題: | Comparative Safety and Effectiveness of Inhaled Corticosteroid and Long-Acting β2-Agonist Combinations in Patients With COPD | 作者: | Chang, Ting-Yu JUNG-YIEN CHIEN Wu, Chung-Hsuen Dong, Yaa-Hui FANG-JU LIN |
關鍵字: | COPD; acute exacerbation; inhaled corticosteroids; pneumonia | 公開日期: | 五月-2020 | 出版社: | ELSEVIER | 卷: | 157 | 期: | 5 | 起(迄)頁: | 1117 | 來源出版物: | Chest | 摘要: | The differential risk of pneumonia among inhaled corticosteroid (ICS) use in patients with COPD requires more investigation, especially regarding beclomethasone-containing inhalers. The goal of this study was to compare the risk and benefit profile of different ICS/long-acting β2-agonist (LABA) combinations in patients with COPD. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/516778 | ISSN: | 00123692 | DOI: | 10.1016/j.chest.2019.12.006 | SDG/關鍵字: | beclometasone; beta 2 adrenergic receptor stimulating agent; budesonide plus formoterol; corticosteroid; fluticasone propionate plus salmeterol; formoterol; beclometasone; beta 2 adrenergic receptor stimulating agent; bronchodilating agent; budesonide; corticosteroid; fluticasone; formoterol fumarate; glucocorticoid; salmeterol xinafoate; aged; Article; chronic obstructive lung disease; cohort analysis; comparative study; disease exacerbation; disease severity; drug efficacy; drug safety; female; follow up; hazard ratio; human; major clinical study; male; outcome assessment; pneumonia; priority journal; propensity score; proportional hazards model; retrospective study; risk benefit analysis; sensitivity analysis; Taiwan; chronic obstructive lung disease; combination drug therapy; drug combination; inhalational drug administration; metered dose inhaler; middle aged; Administration, Inhalation; Adrenal Cortex Hormones; Adrenergic beta-2 Receptor Agonists; Aged; Beclomethasone; Bronchodilator Agents; Budesonide; Drug Combinations; Drug Therapy, Combination; Female; Fluticasone; Formoterol Fumarate; Glucocorticoids; Humans; Male; Metered Dose Inhalers; Middle Aged; Pneumonia; Propensity Score; Pulmonary Disease, Chronic Obstructive; Retrospective Studies; Salmeterol Xinafoate; Taiwan |
顯示於: | 臨床藥學研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。